Vanta Bioscience Limited share price
BSE: VANTABIO
Key numbers
- Market cap
- ₹ 13.9 Cr
- Current price
- ₹ 19.56
- 52-week high / low
- ₹ 29 / 15
- Stock P/E
- 130.4
- Book value
- ₹ 28.9
- Dividend yield
- 0.00%
- ROCE
- 1.1%
- ROE
- 0.6%
- Debt to equity
- 1.80
- Sales growth (3 yrs)
- -33.8%
- Profit growth (3 yrs)
- -
- 1-year return
- -19.3%
About Vanta Bioscience Limited
Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. The company offers a range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. It also provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, and chronic; toxicokinetics assessment, CoA and dose formulation analysis, 5 batch analysis, and studies on behavior in water, soil and air, bioaccumulation, as well as acute 6 pack, carcinogenicity, genetic toxicity, DART, eco-toxicity, and alternative to animal studies. In addition, it offers diet formulation services, which include starter material processing, proximate and composition analysis, diet balancing and formulation, irradiation, and packaging and labeling; and batch release pharmacopoeia tests, such as pyrogen testing, stability studies, and abnormal toxicity and impurity profiling. Further, the company provides services to…
Peers in Diagnostics & Research
Data for information only, not investment advice. Prices end of day.